medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2010, Number 5

<< Back Next >>

Rev ADM 2010; 67 (5)

Oral prevention, treatment and rehabilitation in cancer patients. The importance of comprehensive multidisciplinary approach

Reyes VCA, Gallegos HF, García HMA, Bustos TM, Nambo LMJ, Silva A

Language: Spanish
References: 45
Page: 210-216
PDF size: 128.10 Kb.


ABSTRACT

Background: The rate of occurrence of oral cancer has increased exponentially over the last decade. The World Health Organization (WHO) reports that it is now the sixth most common cause of cancer worldwide. Surgery, chemotherapy and radiotherapy are treatments associated with clinically significant oral side effects, such as severe oral mucositis, oral candidiasis, xerostomia, ulcers, caries, periodontitis, osteonecrosis and infections; therefore, oral health should be assessed and maintained both prior to cancer treatment and during follow up.
Discussion: Approximately 80% of patients given chemotherapy, experience some kind of oral complication, with almost all of those receiving radiotherapy in the head and neck areas developing some degree of mucositis and oral cavity complication, factors that could potentially compromise the delivery of optimal cancer therapy protocols. Dental and oral care is of extremely importance to ensure that the quality of life of patients is good, both during and after cancer treatment.
All cancer centers should establish a Department of Stomatology to provide assessments, diagnosis and treatment to eliminate and/or minimize the oral complications associated with cancer therapies, within an integrated working relationship and multidisciplinary team approach. The aim of the present paper is to define the role played by the various subspecialties involved in oral health.
Conclusions: Departments of Stomatology should be incorporated into the process of diagnosis and treatment of oncologic diseases.


REFERENCES

  1. Reyes C. Perspectivas y Expectativas de la Odontología frente al cáncer oral. Cirugía y Cirujanos 2009; 77:1-2.

  2. Oral Complications of Chemotherapy and Head/Neck Radiation: National Cancer Institute. (Actualizado en 2008, Jun 11; consultado en 2009, Abril 15). Disponible en: http://www.cancer.gov/cancertopics/pdq/supportivecare/oralcomplications/HealthProfessional/page2

  3. Rodríguez CS. Tumores de Cabeza y Cuello. 2a Ed. México: Manual Moderno; 2003. p.427-441.

  4. Estilo C, Huryn J, Kraus D, Sklar C, Wexler L, Wolden S, et al. Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: The Memorial Sloan-Kettering Cancer Center experience. Journal of Pediatric Hematology/ Oncology. 2003; 25(3):215-222.

  5. Ramos M, Lee A, Lee R, Bohle G. III, Huryn J, Estilo C. Dental assessment of the patient undergoing hematopoietic stem cell transplantation: the utility of a classification system. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. 2007; 103(6):793-794.

  6. Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, et al. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2006 38(3):237-242.

  7. Hong C, Lockhart PB, Brennan MT. Analysis of the incidence of oral complications from cancer chemo- and/or radiation therapy in pediatric patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. 2007; 103(6):789.

  8. Treister N, Sonis S. Mucositis: biology and management. Current Opinion in Otolaryngology & Head & Neck Surgery. 2007;15(2):123-129.

  9. Estilo C, Van Poznak CH, Williams T, Evtimovska E, Tkach L, Halpern J, et al. Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: A retrospective study: 8088. Journal of Clinical Oncology.2004; 22(14):750.

  10. Raut A , Huryn J, Hwang F, Zlotolow I. Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics.2001; 92(1):49-55.

  11. Petersen P. Strengthening the prevention of oral cancer: the WHO perspective. Community Dentistry & Oral Epidemiology. 2005; 33(6):397-399.

  12. Servicio Dental del Departamento de Cirugía. Memorial Sloan-Kettering Cancer Center; (Actualizado en 2009; consultado en 2009, Abril 10). Disponible en: http://www.mskcc.org/mskcc/html/69088.cfm

  13. Burket LW: Medicina Bucal. Diagnóstico y Tratamiento: Cáncer Bucal. 6ta.ed: Interamericana; México. 1973. p.562-568.

  14. Gallegos J. Lesiones preneoplásicas de la cavidad bucal: detección y diagnóstico oportuno. Cirugía y Cirujanos 2008; 76:3, 197-198.

  15. Guneri P, Cankaya H. Importance of a dental approach in head and neck cancer therapy. Asia-Pacific Journal of Clinical Oncology. 2005; 1(4):114-119.

  16. Toljanic J, Eckert S, Roumanas E, Beumer J, Huryn J, Zlotolow I, et al. Osseointegrated craniofacial implants in the rehabilitation of orbital defects: an update of a retrospective experience in the United States. Journal of Prosthetic Dentistry. 2005; 94(2):177-182.

  17. Lerner T, Huryn J. Orbital prosthesis with a magnetically retained ocular component supported by osseointegrated implants. Journal of Prosthetic Dentistry. 1993; 69(4):378-380.

  18. Zlotolow I, Hur yn J, Piro J, Lenchewski E, Hidalgo D. Osseointegrated implants and functional prosthetic rehabilitation in microvascular fibula free flap reconstructed mandibles. American Journal of Surgery. 1992; 164(6):677-681.

  19. Bohle G, Mitcherling W, Mitcherling J, Johnson R, Bohle GIII. Immediate obturator stabilization using mini dental implants. Journal of Prosthodontics. 2008; 17(6): 482-486.

  20. Teoh K, Huryn J, Patel S, Halpern J, Tunick S, Wong HB, et al. Implant prosthodontic rehabilitation of fibula free-flap reconstructed mandibles: a Memorial Sloan-Kettering Cancer Center review of prognostic factors and implant outcomes. International Journal of Oral and Maxillofacial Implants. 2005; 20(5):738-746.

  21. Teoh K, Patel S, Hwang F, Huryn J, Verbel D, Zlotolow I. Prosthetic intervention in the era of microvascular reconstruction of the mandible. A retrospective analysis of functional outcome. International Journal of Prosthodontics. 2005; 18(1):42-54.

  22. Bernhart J, Huryn M, Disa J, Shah J, Zlotolow I. Hard palate resection, microvascular reconstruction, and prosthetic restoration: a 14-year retrospective analysis. Head and Neck. 2003; 25(8):671-680.

  23. Shaha A, Cordeiro P, Hidalgo D, Spiro R, Strong E, Zlotolow I, et al. Resection and immediate microvascular reconstruction in the management of osteoradionecrosis of the mandible. Head Neck. 1997;19(5):406-411.

  24. Huryn J, Zlotolow I, Piro J, Lenchewski E. Osseointegrated implants in microvascular fibula free flap reconstructed mandibles. Journal of Prosthetic Dentistry. 1993; 70(5):443-446.

  25. Sulaiman F, Huryn J, Zlotolow I. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. Journal of Oral and Maxillofacial Surgery. 2003; 61(10):1123-1131.

  26. Terezakis S, Bohle GIII, Lee N. Fistula formation afterpostoperative radiation treatment for paranasal sinus cancer. American Journal of Clinical Oncology. 2008; 31(2):199-204.

  27. Estilo C, Williams T, Evtimovska E, Tkach L, Halpern J, Tunick S, et al. Osteonecrosis of the maxilla and mandible: possible druginduced complication of bisphosphonate therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. 2004; 97(4):449-450.

  28. Estilo C, Fornier M, Farooki A, Carlson D, Bohle GIII, Huryn J. Osteonecrosis of the jaw related to bevacizumab. Journal of Clinical Oncology. 2008; 20(24):4037-4038.

  29. Estilo C, Van Poznak C, Wiliams T, Bohle G, Lwin P, Zhou Q, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist. 2008; 13(8):911-920.

  30. Silverman S, American Cancer Society: Oral cáncer: Diagnosis. Complications of Treatment: 5ta ed: PMPH; EUA. 2003. p.48-80. p. 113-128.

  31. Miller C, Epstein J, Hall E, Sirois D. Changing oral care needs in the United States: The continuing need for oral medicine. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. 2001; 91(1):34-44.

  32. Bruins H, Koole R, Jolly D. Pretherapy dental decisions in patients with head and neck cancer: A proposed model for dental decision support. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. 1998; 86(3):256-267.

  33. Petersen P, Lennon M. Effective use of fluorides for the prevention of dental caries in the 2 1st centur y: the WHO approach. Community Dentistry & Oral Epidemiology. 2004; 32(5):319-321.

  34. Mumcu G, Inanc N, Ergun T, Ikiz E, Nabid A, Shelley W, et al. Prophylaxis of Radiation-Associated Mucositis in Conventionally Treated Patients With Head and Neck Cancer: A Double-Blind, Phase III, Randomized, Controlled Trial Evaluating the Clinical Efficacy of an Antimicrobial Lozenge Using a Validated Mucositis Scoring System. Journal of Clinical Oncology.2002; 20(19):3956-3963.

  35. Huryn J, Piro J. The maxillary immediate surgical obturator prosthesis. Journal of Prosthetic Dentistry. 1989; 61(3):343-347.

  36. Larsson M, Hedelin B, Johansson I, Athlin E. Eating Problems and Weight Loss for Patients With Head and Neck Cancer: A Chart Review From Diagnosis Until One Year After Treatment. Cancer Nursing. 2005; 28(6):425-435.

  37. Bohle GIII, Rieger J, Huryn J, Verbel D, Hwang F, Zlotolow I. Efficacy of speech aid prostheses for acquired defects of the soft palate and velopharyngeal inadequacy-clinical assessments and cephalometric analysis: a Memorial Sloan-Kettering Study. Head and Neck. 2005; 27(3):195-207.

  38. Kornblith A, Zlotolow I, Gooen J, Huryn J, Lerner T, Strong E, et al. Quality of life of maxillectomy patients using an obturator prosthesis. Head and Neck. 1996; 18(4):323-34.

  39. Base de datos OMS, Danaei et al. Fight Against Cancer: Strategies That Prevent, Cure and Care. 2007. (Actualizado en 2007; consultado en 2009 Mayo 13). Disponible en: http://www.who.int/cancer/publicat/WHOCancerBrochure2007.FINALweb.pdf

  40. Bradley L, Chambers M, Conklin C, Fox P, Garden A, Haveman C, et al. Oral Health in Cancer Therapy. A guide for health care professionals. Dental Oncology Educational Program. (Actualizada 2003; consultado en 2009, Enero 6 ) Disponible en: http://www.doep.org/OHICT_ 2003.pdf

  41. Online Archive. Organización Mundial de la Salud. Ginebra: 2002. (Actualizada en 2008; consultada en 2009, Abril 12). Disponible en: http://www.who.int/infobase/report.aspx?iso=MEX&rid=119&goButton=G

  42. Base de datos . Instituto Mexicano del Seguro Social. México: 2007-2008. (consultada 2009, Abril 13). Disponible en: http://11.254.16.61/INTRANET/

  43. Base de datos. Instituto Mexicano del Seguro Social. México: Sistema de Información Médico Operativo. (SIMO) Hospital de Oncología Centro Médico Nacional Siglo XXI. 2007. Observación no publicada.

  44. Gallegos J, Paredes E, Flores R, Minauro G, Apresa T, Hernández M. Virus del papiloma humano asociado con cáncer de cabeza y cuello. Cirugía y Cirujanos 2007; 75 (3): 151-155.

  45. NCCN Clinical Practice Guidelines in Oncology: National Comprehensive Cancer Network. Fort Washington. ( Actualizada en 2009; consultado en 2009, Marzo 10). Disponible en: http://wwwnccn.org/professionals/physician_gls/f_guidelines.asp




2020     |     www.medigraphic.com